
Abridge
Founded Year
2018Stage
Series E | AliveTotal Raised
$758.5MValuation
$0000Last Raised
$300M | 5 mos agoRevenue
$0000Mosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+21 points in the past 30 days
About Abridge
Abridge focuses on generative artificial intelligence (AI) for clinical conversations within the healthcare sector. The company provides AI solutions that create AI-generated notes intended for use in patient-clinician interactions. It serves healthcare systems, intending to enhance clinician efficiency and nursing documentation. Abridge was formerly known as Intelligible.AI. It was founded in 2018 and is based in Philadelphia, Pennsylvania.
Loading...
Abridge's Product Videos
ESPs containing Abridge
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The clinical documentation solutions market includes companies leveraging technologies to streamline and improve the process of capturing, organizing, and using patient information. It includes solutions such as ambient documentation platforms that can document patient-clinician interactions, extract relevant medical information, and integrate with electronic health record (EHR) systems. Uses case…
Abridge named as Leader among 15 other companies, including Microsoft, Oracle, and Amazon.
Abridge's Products & Differentiators
Abridge for Clinicians
Abridge creates artifacts for 3 masters – billing, clinicians, patients. The technology acts as an intelligent copilot, producing organized drafts and providing interactive tools to accelerate editing, and seamlessly integrates with healthcare software to streamline documentation. Health systems trust Abridge: Science. Founded on CMU roots, Abridge’s research culminated in the first-published and first-to-market AI system for generating SOAP note drafts. Abridge’s cutting-edge ML safeguards providers & patients by focusing on causality, fairness, and transparency. Clinician-led. Abridge is building a solution for providers by providers. Through his experience as a cardiologist, Abridge’s co-founder and CEO saw opportunities to improve the gap between medical conversations and what happens next. Patient value. Abridge is the
Loading...
Research containing Abridge
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Abridge in 16 CB Insights research briefs, most recently on Aug 22, 2025.

Aug 22, 2025 report
Book of Scouting Reports: Generative AI in Healthcare & Life Sciences
Aug 19, 2025
Are AI unicorns starting to move beyond hype?
Jul 24, 2025 report
State of Digital Health Q2’25 Report
May 1, 2025 report
State of AI Q1’25 Report
Apr 17, 2025 report
State of Digital Health Q1’25 Report
Dec 3, 2024 report
Digital Health 50: The most promising digital health startups of 2024Expert Collections containing Abridge
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Abridge is included in 7 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,309 items
Digital Health
12,122 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Telehealth
3,123 items
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
Digital Health 50
200 items
2022's cohort of the most promising digital health startups transforming the healthcare industry. Winners were chosen based on several factors, including data submitted by the companies, proprietary Mosaic scores, company business models and momentum in the market.
Generative AI
2,951 items
Companies working on generative AI applications and infrastructure.
Artificial Intelligence (AI)
20,894 items
Latest Abridge News
Nov 7, 2025
a16z New Media To get a better sense of where our own founders and team find their contrarian ideas, we asked them to send along an underrecognized book or two that shaped their thinking and that they think everyone else in tech should read. Here’s what they shared. Garrett Langley, founder and CEO of Flock Safety Qasar Younis, founder and CEO of Applied Intuition This is perhaps my all-time favorite business book, even though it’s an autobiography. Maybe because it’s hard to separate Sam Walton from Walmart, it seems it’s as much of a story of a business as it is a man. What is particularly impressive about the Sam Walton story is how seemingly straightforward it is: build a good business, treat people well, and attain success. Like Warren Buffet, Walton shows how a few guiding principles followed for long periods of time can have a tremendous impact. Jesse Zhang, cofounder and CEO of Decagon Ashwin Sreenivas, cofounder of Decagon Great book showing the difficulty/non-linear pace of invention and how slow adoption often is. There’s a section of the book that shows how long it took the Wright brothers to convince the army to buy from them. You’d think that building a flying machine would have been an automatic buy from the army, but no! Ali Ghodsi, cofounder and CEO of Databricks Editor’s note: we couldn’t pick just *one* of Ali’s recs, so we’re including them all below. Tarek Mansour, cofounder and CEO of Kalshi Shiv Rao, cofounder and CEO of Abridge Taste matters more than ever in this AI moment. Tanizaki’s essay explores how light, darkness, and shadow shape perception, architecture, materials, even food. It’s a meditation on the power of subtlety, craft, and depth; and it’s a reminder that design and technology are, at their core, cultural acts. David George, general partner and head of Growth fund While Walter Isaacson’s Elon Musk bio gets due credit, Berger’s books capture the chaos, engineering brinkmanship, and survival mindset of SpaceX fighting for its existence. Berger’s books are more about the making of the company and more engineering-heavy than personality-heavy. Sarah Wang, Growth general partner I found this book in my basement in 8th grade, couldn’t put it down, and still re-read it every few years. An immigrant who changed his name, rose to the top of the most American company, fathered the Mustang, got knocked down and picked himself back up to do it again. Timeless and a reminder what to do when you hit tough times. I found this book in my basement in 8th grade, couldn’t put it down, and still re-read it every few years. An immigrant who changed his name, rose to the top of the most American company, fathered the Mustang, got knocked down and picked himself back up to do it again. Timeless and a reminder what to do when you hit tough times. Alex Rampell, Apps general partner Alex Danco, editor-at-large at a16z Sometimes reading fiction is the best way to understand the facts. The Magic Mountain, written by Thomas Mann a century ago, is one of the best books I’ve ever read for helping you “organize your thoughts”: how does everything in the western canon fit together? What really makes western civilization tick, and what makes it come undone? And—maybe life’s great organizing question across all of time and culture—what are you going to do when you face death? The opening page of Crowds and Power gives me goosebumps every time I read it. If you want to understand what makes groups of individuals transform into a single crowd, how individual people can control and direct crowds, and how power can be understood as a property of crowds and their leaders, this is the book for you. David Booth, head of ecosystem at a16z A highly readable guide to how kids (and adults) learn best: by making stuff, playing, and sharing with the world. Author Mitchel Resnick developed the “scratch” programming language while at MIT, and through research shows that creativity grows when children build things that matter to them, experiment freely, and see themselves as capable of shaping the world. He ultimately argues that the rest of school—and life behind it—should be more like kindergarten. Happy reading! a16z New Media Views expressed in “posts” (including podcasts, videos, and social media) are those of the individual a16z personnel quoted therein and are not the views of a16z Capital Management, L.L.C. (“a16z”) or its respective affiliates. a16z Capital Management is an investment adviser registered with the Securities and Exchange Commission. Registration as an investment adviser does not imply any special skill or training. The posts are not directed to any investors or potential investors, and do not constitute an offer to sell — or a solicitation of an offer to buy — any securities, and may not be used or relied upon in evaluating the merits of any investment. The contents in here — and available on any associated distribution platforms and any public a16z online social media accounts, platforms, and sites (collectively, “content distribution outlets”) — should not be construed as or relied upon in any manner as investment, legal, tax, or other advice. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment. Any projections, estimates, forecasts, targets, prospects and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others. Any charts provided here or on a16z content distribution outlets are for informational purposes only, and should not be relied upon when making any investment decision. Certain information contained in here has been obtained from third-party sources, including from portfolio companies of funds managed by a16z. While taken from sources believed to be reliable, a16z has not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation. In addition, posts may include third-party advertisements; a16z has not reviewed such advertisements and does not endorse any advertising content contained therein. All content speaks only as of the date indicated. Under no circumstances should any posts or other information provided on this website — or on associated content distribution outlets — be construed as an offer soliciting the purchase or sale of any security or interest in any pooled investment vehicle sponsored, discussed, or mentioned by a16z personnel. Nor should it be construed as an offer to provide investment advisory services; an offer to invest in an a16z-managed pooled investment vehicle will be made separately and only by means of the confidential offering documents of the specific pooled investment vehicles — which should be read in their entirety, and only to those who, among other requirements, meet certain qualifications under federal securities laws. Such investors, defined as accredited investors and qualified purchasers, are generally deemed capable of evaluating the merits and risks of prospective investments and financial matters. There can be no assurances that a16z’s investment objectives will be achieved or investment strategies will be successful. Any investment in a vehicle managed by a16z involves a high degree of risk including the risk that the entire amount invested is lost. Any investments or portfolio companies mentioned, referred to, or described are not representative of all investments in vehicles managed by a16z and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. A list of investments made by funds managed by a16z is available here: https://a16z.com/investments/ . Past results of a16z’s investments, pooled investment vehicles, or investment strategies are not necessarily indicative of future results. Excluded from this list are investments (and certain publicly traded cryptocurrencies/ digital assets) for which the issuer has not provided permission for a16z to disclose publicly. As for its investments in any cryptocurrency or token project, a16z is acting in its own financial interest, not necessarily in the interests of other token holders. a16z has no special role in any of these projects or power over their management. a16z does not undertake to continue to have any involvement in these projects other than as an investor and token holder, and other token holders should not expect that it will or rely on it to have any particular involvement. With respect to funds managed by a16z that are registered in Japan, a16z will provide to any member of the Japanese public a copy of such documents as are required to be made publicly available pursuant to Article 63 of the Financial Instruments and Exchange Act of Japan. Please contact compliance@a16z.com to request such documents. For other site terms of use, please go here . Additional important information about a16z, including our Form ADV Part 2A Brochure, is available at the SEC’s website: http://www.adviserinfo.sec.gov . Want more a16z?
Abridge Frequently Asked Questions (FAQ)
When was Abridge founded?
Abridge was founded in 2018.
Where is Abridge's headquarters?
Abridge's headquarters is located at 30 South 15th Street, Philadelphia.
What is Abridge's latest funding round?
Abridge's latest funding round is Series E.
How much did Abridge raise?
Abridge raised a total of $758.5M.
Who are the investors of Abridge?
Investors of Abridge include Andreessen Horowitz, Khosla Ventures, Bessemer Venture Partners, CVS Health Ventures, Spark Capital and 37 more.
Who are Abridge's competitors?
Competitors of Abridge include Hippocratic AI, Pieces, Amalgam Rx, Ambience, Beam Health and 7 more.
What products does Abridge offer?
Abridge's products include Abridge for Clinicians.
Who are Abridge's customers?
Customers of Abridge include UPMC.
Loading...
Compare Abridge to Competitors

DeepScribe automates medical documentation through its platform in the healthcare sector. It provides a medical scribe that captures patient conversations and generates clinical notes, as well as coding support and note personalization for clinicians. It serves the healthcare industry, focusing on specialty care and value-based care. It was founded in 2017 and is based in San Francisco, California.

Nabla provides ambient artificial intelligence (AI) technology focused on healthcare documentation and workflow efficiency. The company offers an AI assistant that generates clinical notes in real-time, integrated into electronic health records (EHRs), to address clinician workload and patient care. Nabla's solutions support various medical specialties and can be customized for different clinical needs. It was founded in 2018 and is based in Paris, France.

Corti develops artificial intelligence models for the healthcare sector. Its offerings include AI models that understand medical terminology and patient interactions, designed to integrate into healthcare applications via an application programming interface. The company was founded in 2016 and is based in Copenhagen K, Denmark.

Ambience operates as a healthcare technology company that provides ambient artificial intelligence (AI) solutions for clinical documentation, coding, and patient summaries. The company has a platform that integrates with electronic health records (EHRs) to support patient care, specialty workflows, documentation accuracy, and billing processes. Ambience serves the healthcare sector with tools aimed at addressing clinician burnout. It was founded in 2020 and is based in San Francisco, California.

Abstractive Health focuses on artificial intelligence solutions for the healthcare sector, particularly in the area of clinical note management. The company provides a physician AI assistant that summarizes medical records, allowing for the reading and writing of clinical notes. Abstractive Health's technology integrates with existing healthcare systems, facilitating chart retrieval and AI-generated clinical summaries. It was founded in 2022 and is based in New York, New York.

Suki AI operates develops voice solutions for the healthcare sector. The company offers Suki Assistant, which supports healthcare documentation and administrative tasks, and Suki Platform, enabling healthcare technology companies to integrate artificial intelligence (AI) features. Suki AI serves the healthcare industry, providing tools for clinician efficiency and electronic health record (EHR) integration. Suki AI was formerly known as Robin AI. It was founded in 2017 and is based in Redwood City, California.
Loading...

